Potential new therapeutic targets for Schistosomiasis
Nature Communications
2011년8월10일
Modification of the DNA of the parasitic flatworm Schistosoma mansoni that gives rise to the disease Schistomiasis is identified in Nature Communications. The finding could potentially be used to identify targets to control these pathogens which cause one of the world’s most prevalent parasitic diseases.
Schistomiasis is a chronic and debilitating disease caused by blood flukes. Karl Hoffmann and colleagues show for the first time that the genomic DNA of the blood fluke Schistosoma mansoni is methylated and they also identify proteins that are likely to mediate this modification of the DNA. They found that chemical inhibition of these proteins with the FDA approved chemotherapeutic drug 5-azacytidine, reduced methylation and also reduced the egg production of female blood flukes and caused morphological abnormalities of the remaining eggs.
These findings suggest that targeting the proteins that methylate the DNA of the flood fluke could be used in their control.
doi: 10.1038/ncomms1433
리서치 하이라이트
-
6월24일
Sport science: New wearable sensor to measure neck strain may detect potential concussionScientific Reports
-
6월23일
Scientific community: Women credited less than men in scientific paper authorshipNature
-
6월17일
Health technology: New cost-effective smartphone test for middle ear functionCommunications Medicine
-
6월16일
An exercise-inducible molecule that suppresses appetiteNature
-
6월16일
Cancer: Signatures of structural genomic variation in cancerNature
-
6월10일
Animals: Genetic clues to how dogs became man’s best friendsScientific Reports